CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis

Eleonora Dondossola, Roberto Rangel, Liliana Guzman-Rojas, Elena M. Barbu, Hitomi Hosoya, Lisa S. St. John, Jeffrey J. Molldrem, Angelo Corti, Richard L. Sidman, Wadih Arap, Renata Pasqualini

Research output: Contribution to journalArticlepeer-review


Angiogenesis is fundamental to tumorigenesis and an attractive target for therapeutic intervention against cancer. We have recently demonstrated that CD13 (aminopeptidase N) expressed by nonmalignant host cells of unspecified types regulate tumor blood vessel development. Here, we compare CD13 wild-type and null bone marrow-transplanted tumor-bearing mice to show that host CD13+ bone marrow-derived cells promote cancer progression via their effect on angiogenesis. Furthermore, we have identified CD11b+CD13+ myeloid cells as the immune subpopulation directly regulating tumor blood vessel development. Finally, we show that these cells are specifically localized within the tumor microenvironment and produce proangiogenic soluble factors. Thus, CD11b+CD13+ myeloid cells constitute a population of bone marrow-derived cells that promote tumor progression and metastasis and are potential candidates for the development of targeted antiangiogenic drugs.

Original languageEnglish
Pages (from-to)20717-20722
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number51
Publication statusPublished - Dec 17 2013


  • Mouse models
  • Protease
  • Stromal cells
  • Vascular pericytes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis'. Together they form a unique fingerprint.

Cite this